Cargando…
The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study
Whether number of examed lymph nodes (ELNs) would bring survival benefit for patients with negative lymph nodes after modified radical mastectomy (MRM) is uncertain. In our study, using the Surveillance Epidemiology and End Results (SEER) database between 2004 and 2009, we screened the appropriate p...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630362/ https://www.ncbi.nlm.nih.gov/pubmed/29029462 http://dx.doi.org/10.18632/oncotarget.20052 |
_version_ | 1783269208909414400 |
---|---|
author | Chi, Huiying Zhang, Chenyue Wang, Haiyong Wang, Zhehai |
author_facet | Chi, Huiying Zhang, Chenyue Wang, Haiyong Wang, Zhehai |
author_sort | Chi, Huiying |
collection | PubMed |
description | Whether number of examed lymph nodes (ELNs) would bring survival benefit for patients with negative lymph nodes after modified radical mastectomy (MRM) is uncertain. In our study, using the Surveillance Epidemiology and End Results (SEER) database between 2004 and 2009, we screened the appropriate patients with negative lymph nodes underwent MRM. The Cox proportional hazard analysis was used to determine the effect of number of ELNs on cancer specific survival (CSS). The results showed that the number of ELNs was not an independent prognostic factor on CSS (P = 0.940). Then the X-tile mode was used to determine the appropriate threshold for ELNs count. The results showed that 9 was the appropriate cut-off point. Next, the log-rank χ(2) test was used to analyze the CSS based on different subgroup variables. The results showed that some subgroup variables including age < 50/ ≥ 50, grade I/III, AJCC T1/T2, ER positive/negative and PR positive/negative ,demonstrated significant CSS benefits among the patients with the number of ELNs ≤ 9 (all, P < 0.05). However, three subgroup variables including grade II, AJCC T3 and AJCC T4, the patients with the number of ELNs ≤ 9 did not bring significant CSS benefits (all, P > 0.1). In conclusion, our study demonstrated that the number of ELNs was not an independent prognostic factor on CSS, and 9 can be selected as the appropriate cut-off point of ELNs for patients with negative lymph nodes who underwent MRM. |
format | Online Article Text |
id | pubmed-5630362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56303622017-10-12 The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study Chi, Huiying Zhang, Chenyue Wang, Haiyong Wang, Zhehai Oncotarget Research Paper Whether number of examed lymph nodes (ELNs) would bring survival benefit for patients with negative lymph nodes after modified radical mastectomy (MRM) is uncertain. In our study, using the Surveillance Epidemiology and End Results (SEER) database between 2004 and 2009, we screened the appropriate patients with negative lymph nodes underwent MRM. The Cox proportional hazard analysis was used to determine the effect of number of ELNs on cancer specific survival (CSS). The results showed that the number of ELNs was not an independent prognostic factor on CSS (P = 0.940). Then the X-tile mode was used to determine the appropriate threshold for ELNs count. The results showed that 9 was the appropriate cut-off point. Next, the log-rank χ(2) test was used to analyze the CSS based on different subgroup variables. The results showed that some subgroup variables including age < 50/ ≥ 50, grade I/III, AJCC T1/T2, ER positive/negative and PR positive/negative ,demonstrated significant CSS benefits among the patients with the number of ELNs ≤ 9 (all, P < 0.05). However, three subgroup variables including grade II, AJCC T3 and AJCC T4, the patients with the number of ELNs ≤ 9 did not bring significant CSS benefits (all, P > 0.1). In conclusion, our study demonstrated that the number of ELNs was not an independent prognostic factor on CSS, and 9 can be selected as the appropriate cut-off point of ELNs for patients with negative lymph nodes who underwent MRM. Impact Journals LLC 2017-08-07 /pmc/articles/PMC5630362/ /pubmed/29029462 http://dx.doi.org/10.18632/oncotarget.20052 Text en Copyright: © 2017 Chi et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Chi, Huiying Zhang, Chenyue Wang, Haiyong Wang, Zhehai The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study |
title | The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study |
title_full | The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study |
title_fullStr | The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study |
title_full_unstemmed | The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study |
title_short | The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study |
title_sort | appropriate number of elns for lymph node negative breast cancer patients underwent mrm: a population-based study |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630362/ https://www.ncbi.nlm.nih.gov/pubmed/29029462 http://dx.doi.org/10.18632/oncotarget.20052 |
work_keys_str_mv | AT chihuiying theappropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy AT zhangchenyue theappropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy AT wanghaiyong theappropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy AT wangzhehai theappropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy AT chihuiying appropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy AT zhangchenyue appropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy AT wanghaiyong appropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy AT wangzhehai appropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy |